Norwegian Aqua has a lounge exclusive to guests in the most expensive Haven suites. There, they get attentive service and a ...

A battle to build an extension with a balcony on the back of a house has failed ... overlooking – because of its “relatively low 1.1 metre height”. They said that increasing the height ...

CVS Caremark to list Wegovy as preferred GLP-1 drug on top formularies starting July 1, 2025. Novo Nordisk plans continued collaboration with CVS to widen Wegovy access. Unlock your all-in-one ...

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying patients. Semaglutide, the first weekly GLP-1 RA for weight management ...

Novo Nordisk's stock was up about 3% in early trading. Patients will be able to access the popular GLP-1 through Novo Nordisk's online pharmacy, NovoCare, directly from Hims & Hers and telehealth ...

SAO PAULO, April 7 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil to boost ...

Lexicon Pharmaceuticals secured a licensing deal with Novo Nordisk for LX9851, with potential payments totaling $1 billion-plus royalties. Preclinical data show that LX9851 enhances weight loss ...

Novo Nordisk (NVO) plans to run studies on how its GLP-1 class of weight loss/diabetes drug can help people deal with addiction, Martin Holst Lange, the Danish pharma’s head of development ...

Now that Novo Nordisk’s supply has stabilized, Lilly can capture more share as doctors and patents have choices. Also, Lilly’s manufacturing investments, including a $2.1 billion expansion in ...

Rescued NASA astronauts deliver message to Trump, Musk after 'incredible' nine months in space Trump forces Canada to rethink trade and energy flows ABC Renewal Status Report: ‘Grey's', ‘9-1-1 ...

LISBON (Reuters) - U.S. private equity fund Lone Star and Portuguese authorities are set to share 1.3 billion euros ($1.34 billion) when Novo Banco makes its first dividend payout in the coming ...

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive signals” are emerging when it comes to the consistent supply of GLP-1 ...